LSV Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.65M | Sell |
|
|||||
|
2024
Q1 | $1.75M | Sell |
|
|||||
|
2023
Q4 | $2.05M | Sell |
|
|||||
|
2023
Q3 | $6.45M | Hold |
|
|||||
|
2023
Q2 | $7.95M | Buy |
|
|||||
|
2023
Q1 | $6.92M | Buy |
|
|||||
|
2022
Q4 | $4.43M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $153K | Sell |
|
|||||
|
2020
Q3 | $586K | Sell |
|
|||||
|
2020
Q2 | $8.08M | Sell |
|
|||||
|
2020
Q1 | $14.7M | Sell |
|
|||||
|
2019
Q4 | $22.2M | Sell |
|
|||||
|
2019
Q3 | $26.1M | Buy |
|
|||||
|
2019
Q2 | $22.5M | Buy |
|
|||||
|
2019
Q1 | $12.6M | Buy |
|
|||||
|
2018
Q4 | $3.35M | Sell |
|
|||||
|
2018
Q3 | $6.19M | Sell |
|
|||||
|
2018
Q2 | $44.8M | Sell |
|
|||||
|
2018
Q1 | $45.3M | Buy |
|
|||||
|
2017
Q4 | $39.2M | Buy |
|
|||||
|
2017
Q3 | $13.6M | Buy |
|